Skip to Content

Aviva PLC

AV.: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
GBX 182.00MnyczSkswbbfpq

Aviva Has Streamlined and Rebalanced Its Portfolio With a Little More Deleveraging Left to Go

Business Strategy and Outlook

With the divestment of peripheral operations and geographies, Aviva has tilted its portfolio to a regional focus and more balance across product lines. International growth took the company increasingly away from general insurance. This is back to levels of contribution seen historically. Aviva is still a life and savings business predominantly, generating close to three quarters of its earnings from protection and health, equity release, annuities, and long-term savings. Health insurance is increasingly important, serving 4.5 million retail customers and around 3.3 million customers who get health insurance through their employment. With elevated national health service waitlists, there is increasing demand for health insurance. In protection, the company’s products are split equally between individual and group insurance. Using individual protection as a benchmark, 10% of sales are direct, 10% are sold without advice but intermediated, and protection sales are heavily intermediated. Aviva is looking to make individual protection increasingly automated. Health and protection make up around 10% of operating profit from UK and Ireland life and savings.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of AV. so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center